Graft-Versus-Host Disease Clinical Trial
— ORALGVHDOfficial title:
Clinical and Histological Evaluation of Chronic Graft-Versus Host Disease (cGVHD) in Oral Mucosa
Verified date | May 2009 |
Source | University of Sao Paulo |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Introduction: Graft-versus-host-disease (GVHD) is the major cause of morbidity and mortality
in patients submitted to the Bone Marrow Transplantation (BMT). The oral manifestations can
be very debilitating and interfere in the results of medical therapy, leading to systemic
complications, committing the prognosis and quality of life of the patient.
The early diagnosis can be done through biopsies of oral mucosa with or without apparent
injury clinic. The association between the clinical and histopathological tables of GVHD,
especially through the use of recent consensus established in these areas, can bring new
benefits to physicians.
Objective: This study aims to apply and compare the two classifications histological to GVHD,
Horn (1995) and Consensus (2006) in specimens obtained from clinical oral lesions suggestive
of GVHD; correlate them with clinical classification according Akpek (2001) and with the
survival of the patients.
Status | Completed |
Enrollment | 41 |
Est. completion date | April 2009 |
Est. primary completion date | October 2008 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A and older |
Eligibility |
Inclusion Criteria: - all patients with clinical signs of oral GVHD that underwent oral biopsy Exclusion Criteria: - samples without epithelium or minor salivary glands |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
University of Sao Paulo |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | The histological classification according Horn showed that in most cases there was presence of GVHD with low degrees of severity; Already classification of the Consensus showed that there were in full presence of GVHD of moderate degree. | during the survey data, and analysis of specimens |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT01428973 -
Minitransplants With HLA-matched Donors : Comparison Between 2 GVHD Prophylaxis Regimens
|
Phase 2 | |
Not yet recruiting |
NCT00749164 -
Allogeneic Mesenchymal Stem Cell for Graft-Versus-Host Disease Treatment
|
Phase 1/Phase 2 | |
Completed |
NCT00993343 -
Randomized Trial Comparing Sirolimus and Tacrolimus Versus Cyclosporine and Methotrexate as Graft-versus-host Disease (GVHD) Prophylaxis After Allogeneic Stem Cell Transplantation
|
Phase 3 | |
Completed |
NCT00360685 -
Tacrolimus and Mycophenolate Mofetil (MMF) in GVHD Prophylactic Regimen Compared to Tacrolimus and Methotrexate (MTX
|
N/A | |
Active, not recruiting |
NCT04503616 -
Cyclophosphamide, Abatacept, and Tacrolimus for GvHD Prevention
|
Phase 1/Phase 2 | |
Terminated |
NCT02080195 -
Nonmyeloablative Conditioning and Transplantation for Patients With Refractory Systemic Lupus Erythematosus (SLE)
|
Phase 1/Phase 2 | |
Completed |
NCT02193880 -
Safety of Post-transplant Alpha-beta Depleted T-cell Infusion Following Haploidentical Stem Cell Transplant (Haplo SCT)
|
N/A | |
Completed |
NCT02942173 -
CD45RA Depleted T-cell Infusion for Prevention of Infections After TCRab/CD19-depleted Allo-HSCT
|
Phase 2/Phase 3 | |
Completed |
NCT02145403 -
Phase 1/2 Study of Carfilzomib for the Prevention of Relapse and GVHD in Allo-HCT for Hematologic Malignancies
|
Phase 1/Phase 2 | |
Recruiting |
NCT01941394 -
Mesenchymal Stem Cells Infusion for aGVHD Prophylaxis Transplantation
|
Phase 2 | |
Completed |
NCT00141713 -
The Use of Etanercept (Enbrel®) in the Treatment of Acute Graft-Versus-Host Disease
|
Phase 2 | |
Recruiting |
NCT01991301 -
Carfilzomib for the Prevention of Graft Versus Host Disease
|
Phase 1 | |
Completed |
NCT00408928 -
Study on the Safety and Effectiveness of VELCADE® in the Treatment of Graft-Versus-Host Disease
|
Phase 2 | |
Completed |
NCT01633229 -
Bone Marrow Stromal Cell Infusions for Stem Cell Transplant Complications
|
Phase 1 | |
Completed |
NCT05856058 -
To Assess SHR0302 Oral Solutions and Tablets in Healthy Subjects Clinical Studies of Relative Bioavailability
|
Phase 1 | |
Completed |
NCT02342613 -
Adoptive Immunotherapy With Activated Marrow Infiltrating Lymphocytes and Cyclophosphamide Graft-Versus-Host Disease Prophylaxis in Patients With Relapse of Hematologic Malignancies After Allogeneic Hematopoietic Cell Transplantation
|
Phase 1 | |
Recruiting |
NCT06423131 -
Prospective Clinical Trial for Children With TCRαβ Depleted vs Traditional Haplo Identicle HSCT
|
N/A | |
Completed |
NCT02144025 -
Prevention of Ocular Graft-Versus-Host Disease With Topical Cyclosporine in Recipients of Allogeneic HSCT
|
Phase 2 | |
Completed |
NCT01369914 -
The Natural History of Graft-Versus-Host Disease in the Eyes
|
||
Completed |
NCT00806728 -
Study of MEDI-507 in With Steroid-Resistant Acute Graft-Versus-Host Disease
|
Phase 1 |